Works by Jun, Dae W.

Results: 3
    1

    A Phase 3 clinical trial validating the potency and safety of an innovative, extra‐long‐acting interferon in chronic hepatitis C.

    Published in:
    JGH Open, 2022, v. 6, n. 11, p. 782, doi. 10.1002/jgh3.12825
    By:
    • Chen, Chi‐Yi;
    • Chuang, Wan‐Long;
    • Qin, Albert;
    • Zhang, Wen‐Hua;
    • Zhu, Li‐Ying;
    • Zhang, Guo‐Qiang;
    • Chen, Jyh‐Jou;
    • Lo, Ching‐Chu;
    • Zhou, Xinmin;
    • Mao, Xiaorong;
    • Shang, Jia;
    • Kuo, Hsing‐Tao;
    • Xie, Wen;
    • Chen, Chien‐Hung;
    • Lo, Gin‐Ho;
    • Jun, Dae W;
    • Dang, Shuangsuo;
    • Tsai, Chan‐Yen;
    • Wang, Ting‐Fang;
    • Lai, Hsin‐Hui
    Publication type:
    Article
    2

    Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1430, doi. 10.1111/apt.15718
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon‐Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L.‐H.;
    • Wong, Vincent W.‐S.;
    • Razavi, Homie
    Publication type:
    Article
    3

    Modelling NAFLD disease burden in four Asian regions—2019‐2030.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 801, doi. 10.1111/apt.15673
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon-Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L. ‐H.;
    • Wong, Vincent W. ‐S.;
    • Razavi, Homie
    Publication type:
    Article